Hepatic Impairment: Hepatic metabolism accounts for almost 100% of diclofenac sodium extended-launch tablets elimination, so individuals with hepatic disease may involve minimized doses of diclofenac sodium prolonged-release tablets when compared to sufferers with usual hepatic function. As a result of these dangers, limit dose and period of diclofenac sodium prolonged-release https://diclofenacsodium47912.dbblog.net/3091856/not-known-details-about-diclofenac-sodium